Medsafe approves first product to help people quit vaping
Medsafe has approved New Zealand's first nicotine replacement therapy specifically for those trying to quit vaping.Summary
Medsafe has approved the first nicotine replacement therapy (NRT) product specifically designed to help people quit vaping in New Zealand. The Asthma and Respiratory Foundation praised the decision as a crucial step in addressing the country's growing vaping epidemic, noting that nicotine dependence from vaping is a significant and increasing problem. A 2024 survey revealed that 20% of Year 12 students and 26% of Year 13 students reported recent vaping, a substantial rise from previous years. While welcoming the new cessation product, the Foundation continues to advocate for stricter regulations, including halting new vape retailers, banning sales in general stores, investing in education, and reviewing the prescription model. They also expressed disappointment at being denied government funding for their school workshops and community programs.
(Source：Rnz Co Nz)
